Impact of Disease on the Concept of End-of-life Decisions of the Elderly in the Community
Recruitment status was: Not yet recruiting
|Study Design:||Observational Model: Ecologic or Community
Time Perspective: Prospective
- Sick Elderly in the Community [ Time Frame: One year ]Questionnaires regarding end-of-life decisions and perception of illness
|Study Start Date:||February 2012|
|Estimated Study Completion Date:||January 2013|
|Estimated Primary Completion Date:||January 2013 (Final data collection date for primary outcome measure)|
|Sick elderly in community||
Questionnaire to be distributed among sick elderly in the community
This study is descriptive adapters which examines the relationship between illness perception and preferences of end of life decisions in the elderly in the community.
Population and sample: The target population will be elderly and healthy community elderly population was accessible due to a special branch of the club together in the center of the country. Sample to be a sample of convenience. The study will include 88 seniors aged 65 and over to get the power of 0.80 and alfa 0.05, Tools: The study used three tools.
- The first tool is a questionnaire on demographic and clinical details
- The second tool questionnaire the Long term support program (LTSP)
- The third tool is a questionnaire perception of the disease Revised Illness Perceptions Questionnaire (IPQR)
The research process:
Investigator will present the proposal to the Commissioner Fund hospitals and request approval for the study. After receiving approval from the director Department of Health fund the hospital will make data collection phase HMO, days and hours of reception. Interrogator he is to partition the questionnaires and will be present when filling out the questionnaires to help, if and created a situation of lack of understanding of the questionnaires. Scholar, came to the population for the Disabled arriving at the clinic visit, and introduce himself and the subject of research. investigator will indicate questionnaire is anonymous.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01519622
|Contact: Sheriff Khele, MAfirstname.lastname@example.org|
|Meir Medical Center||Not yet recruiting|
|Kfar Saba, Israel|
|Principal Investigator: Sheriff Khele, MA|
|Sub-Investigator: Ali Shalabi, RN, PhD|